The Dangers of Smoking Hookah, E-cigarettes and Vaping

Aug.02.2022
The Dangers of Smoking Hookah, E-cigarettes and Vaping
Waterpipe smoking is just as harmful as cigarette smoking, containing addictive nicotine and known carcinogens. Electronic cigarettes also pose health risks.

Numerous studies indicate that many of the chemicals found in cigarette smoke are also present in hookah smoke.


Evidence suggests that the oily liquid used in electronic cigarettes can cause other lung diseases such as lipoid pneumonia and bronchitis.


Like smoking, hookah contains addictive nicotine.


Lung cancer is becoming a major healthcare challenge in India, with over 10,000 new cases expected in the next five years. It is more prevalent in males (accounting for around 70% of cases) but the incidence rate among females has been steadily increasing over the past decade.


Lung cancer has several risk factors, with the main one being smoking, which accounts for 90% of lung cancer cases. However, some people believe that smoking hookah is a safer and more social alternative to smoking, and does not pose any health risks. Dr. Vishesh Gumdal, an oncologist consultant at the LB Nagar Hyderabad American Cancer Society, has debunked this myth and highlighted some significant health risks associated with it.


Chemicals found in cigarette smoke are also present in waterpipes.


Dr. Gumdal explains that a hookah is a type of smoking device that uses a mixture of tobacco and various flavors to produce smoke. The mixture is heated with charcoal and the smoke is then filtered through a water-filled container before being inhaled by the user through a hose with a mouthpiece.


Although some may believe that the toxicity of hookah smoking is less harmful than traditional cigarette smoking, numerous studies have shown that many chemicals found in cigarette smoke are also present in hookah smoke. More than 50 known carcinogens have been found in hookah smoke. Like cigarettes, hookah contains addicting nicotine. In summary, hookah smoking is just as detrimental as traditional smoking.


The oily liquid used when vaping e-cigarettes can lead to other lung diseases.


Apart from hookah, other smoking technologies such as e-cigarettes can also lead to severe lung diseases. Dr. Gumdal explains that vapor involves the process of heating substances and inhaling the resulting smoke. Devices such as "e-cigarette pens" or "mods" are typically used to heat substances in liquid form until smoke is produced.


He added, "Many of these liquid mixtures contain a variety of flavorings, fragrances, nicotine, and cannabis derivatives. These mixtures are often dissolved in oily alkaline substances. Toxic chemicals such as formaldehyde, acrylonitrile and diacetyl are also inhaled. Many of these chemicals are carcinogenic.


However, there is little scientific evidence linking electronic cigarettes to lung cancer. Part of the reason may be that even in Western countries, these habits are relatively new for people, and it would take decades of research and follow-up on people addicted to this practice to establish a causal relationship between e-cigarettes and lung cancer.


He said that considering the presence of toxic chemicals in the liquids used in e-cigarettes, in his view, over time, more scientific data may link these practices to lung cancer. There is evidence that the oily liquids used in e-cigarettes can cause other lung diseases such as lipoid pneumonia, bronchitis (or popcorn lung), and spontaneous pneumothorax. Therefore, it is best to be safe and avoid addiction to these practices until further research is completed.


Shisha usage is prevalent among young people.


Electronic cigarettes have been completely banned in India since 2019. However, there is currently no national law prohibiting water pipes, which is especially concerning given more scientific evidence linking them to lung disease and lung cancer.


Experts claim that the younger generation is increasingly using hookah due to Western influence on our culture. Commercial establishments offering hookah services seem to be particularly concentrated around many urban educational institutions.


Of particular concern is the widespread use of hookah among young people in India. While there have been some recent improvements in regulations around hookah, parents and guardians must remain vigilant in monitoring their children's use. Schools and other educational institutions should also be encouraged to place a greater emphasis on educating students about the harmful effects of hookah.


Statement:


This article is compiled from third-party information and is intended solely for industry exchange and learning.


This article does not represent the views of 2FIRSTS and we cannot confirm the truthfulness or accuracy of the content. The translation of this article is intended solely for industry exchange and research.


Due to limited translation skills, the translated article may not fully express the original meaning. Please refer to the original text for accuracy.


2FIRSTS maintains complete alignment with the Chinese government in all domestic, Hong Kong/Macau/Taiwan-related, and foreign-related statements and positions.


The copyright of the compiled information belongs to the original media and author. If there is any infringement, please contact us for removal.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

U.S. Health Groups Seek to Overturn FDA Enforcement Discretion for Pending PMTAs as Altria's Helix, NJOY and AVM Move to Intervene
U.S. Health Groups Seek to Overturn FDA Enforcement Discretion for Pending PMTAs as Altria's Helix, NJOY and AVM Move to Intervene
American Vapor Manufacturers (AVM) and Altria subsidiaries Helix Innovations and NJOY filed separate motions on October 7, 2026, seeking to intervene on the FDA's side in a lawsuit challenging its enforcement guidance for certain e-cigarette and nicotine pouch products with pending premarket tobacco product applications (PMTAs). Seven public health and tobacco-control organizations, including the Campaign for Tobacco-Free Kids, sued the agency in July to overturn the policy. AVM argues that vacating the guidance could disrupt orders, inventory, retail distribution and investments in regulatory submissions.
Regulations
Oct.09
Special report|Indonesia's Vape Industry Has 200 Manufacturers and $1.7 Billion in Investment. Could a Regulatory Divide Derail Its Rise as the World's No. 2 Manufacturing Hub After Shenzhen?
Special report|Indonesia's Vape Industry Has 200 Manufacturers and $1.7 Billion in Investment. Could a Regulatory Divide Derail Its Rise as the World's No. 2 Manufacturing Hub After Shenzhen?
Indonesia's Ministry of Industry said at a November 3, 2026, policy forum that the country has about 200 electronic cigarette companies, Rp31 trillion (approximately $1.71 billion) in cumulative industry investment and around 100,000 jobs across the supply chain. The National Narcotics Agency is seeking a comprehensive ban on vape use and circulation, while the industry ministry favors tighter import, product-standard and distribution controls. Indonesia exported approximately $518 million in vaping products in 2025, and Chinese manufacturers including Smoore, GEEKVAPE and Jinjia Group have established local operations. An international logistics specialist interviewed by 2Firsts said more Chinese vape companies began production in Indonesia from the second half of 2025, accompanied by increased shipments of manufacturing equipment and investment in logistics facilities. The regulatory debate comes as Indonesia expands its role in international vaping manufacturing.
Special Report
Nov.05
Iowa Sets November 16 Vape Directory Launch: Unlisted Products Face Sales Ban, Manufacturers $1,000 Daily Fines per Product
Iowa Sets November 16 Vape Directory Launch: Unlisted Products Face Sales Ban, Manufacturers $1,000 Daily Fines per Product
Iowa plans to publish its first vapor products directory on November 16, 2026, after which products not listed will be prohibited from sale or offer for sale in the state. The Department of Revenue expects to begin penalty enforcement on December 17, following an initial 21-business-day period focused on compliance education. Under House File 2677, retailers, distributors and wholesalers selling unlisted products face civil penalties of $300 per product per day, while manufacturers face $1,000 per product per day. Eligibility extends to FDA-authorized products and certain products meeting historical marketing and pending PMTA requirements. The directory program resumed after a federal appeals court vacated a preliminary injunction in July 2026.
Regulations
Nov.05
Arizona Turns to a 50% Retail Vape Tax as Tobacco Tax Revenue Falls 47% From 2008
Arizona Turns to a 50% Retail Vape Tax as Tobacco Tax Revenue Falls 47% From 2008
Arizona's First Things First is pushing for an excise tax equal to 50% of the retail price of vaping products, estimating that the measure could generate about $100 million annually. The agency says its tobacco-tax revenue has fallen 47% from 2008 levels. Arizona has attempted to broaden its nicotine tax base in each of the past two years: a 2025 bill proposed a 50% wholesale-price tax, while a 2026 measure shifted to a 50% retail-price tax covering alternative nicotine products and vapor products. Separately, the state enacted HB 4001 this year to establish a new licensing and sales framework for alternative nicotine products.
Sep.21
US ITC Judge Finds Glas Infringed Two JUUL Vape Patents, Recommends Restrictions on Related Imports——Glas Received FDA Marketing Authorization for Four Vape Pods in May 2026; Proposed Restrictions Remain Under Commission Review
US ITC Judge Finds Glas Infringed Two JUUL Vape Patents, Recommends Restrictions on Related Imports——Glas Received FDA Marketing Authorization for Four Vape Pods in May 2026; Proposed Restrictions Remain Under Commission Review
A U.S. International Trade Commission (USITC) administrative law judge issued an initial determination on October 20, 2026, finding that certain Glas vaping devices, cartridges and components infringed 12 claims across two patents asserted by JUUL, constituting a violation of Section 337 of the Tariff Act of 1930. The judge recommended a limited exclusion order and a cease and desist order against the Glas respondents. Five months earlier, the FDA authorized four Glas e-cigarette pods, including mango, blueberry and two menthol variants. The patent investigation concerns device and cartridge structures and is separate from FDA premarket review. The proposed import restrictions have not become final, and their product-level scope remains unresolved.
company
Nov.05
Kumulus Vape2026 H1 Revenue Falls 8.3% but Profit Rises 24% as B2B Weakens and Consumer Channels Grow
Kumulus Vape2026 H1 Revenue Falls 8.3% but Profit Rises 24% as B2B Weakens and Consumer Channels Grow
French vaping company Kumulus Vape reported first-half 2026 revenue of €25.5 million, down 8.3% year over year, as its core B2B distribution business fell 11% to €21.6 million. B2C and store-network revenue rose 5.6% and 17.8%, respectively. Commercial margin increased to 26.3% from 21.7%, while net profit rose 24.1% to €0.8 million. The company attributed the profitability improvement to catalog optimization, logistics restructuring and the ramp-up of Labster, its in-house production unit for proprietary brands.
Market
Sep.17 by 2Firsts Perspectives